Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Performance test |
yo-yo intermittent recovery test level 1 |
7 days after treatment |
|
Primary |
Changes in nitrates |
Blood plasma will be obtained to measure nitrate concentration |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Primary |
Changes in nitrites |
Blood plasma will be obtained to measure nitrite concentration |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Primary |
Changes in prooxidant status |
Blood plasma will be obtained to measure total oxidative status |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Primary |
Changes in antioxidant status |
Blood plasma will be obtained to measure total antioxidant capacity |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Primary |
Changes in oxidative stress index |
The oxidative stress index will be calculated as the ratio of plasma prooxidant to antioxidant status |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Primary |
Changes in nitrooxidative stress markers |
Blood plasma will be obtained to measure 3-nitrotyrosine concentration |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Primary |
Changes in protein oxidation |
Blood plasma will be obtained to measure advanced protein oxidation products concentration |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Primary |
Changes in nucleic acid oxidation |
Blood plasma will be obtained to measure ox-8-hydroxy-2'-deoxyguanosine (8-OHdG) concentration |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Primary |
Changes in lipids oxidation |
Blood plasma will be obtained to measure thiobarbituric acid reactive substances concentration |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Primary |
Changes in exercise-induced metabolic acidosis |
Arterialized blood will be obtained to measure lactate concentration |
1) Before the performance test 2) 3 minutes after the performance test 3) 10 minutes after the performance test 4) 20 minutes after the performance test |
|
Primary |
Objective Sleep - Time in bed |
Total time spent in bed during the night assessed by sleep radar |
nights 1 - 7 during treatment |
|
Primary |
Objective Sleep - Sleep-onset latency |
The time it takes from when the athlete intends to go to sleep and actually starts to sleep assessed by sleep radar |
nights 1 - 7 during treatment |
|
Primary |
Objective Sleep - Total sleep time |
Total sleep time obtained from sleep onset to time at wake-up assessed by sleep radar |
nights 1 - 7 during treatment |
|
Primary |
Objective Sleep - Light sleep |
Total amount of time in light sleep assessed by sleep radar |
nights 1 - 7 during treatment |
|
Primary |
Objective Sleep - Deep sleep |
Total amount of time in deep sleep assessed by sleep radar |
nights 1 - 7 during treatment |
|
Primary |
Objective Sleep - REM sleep |
Total amount of time in REM sleep assessed by sleep radar |
nights 1 - 7 during treatment |
|
Primary |
Objective Sleep - Sleep efficiency |
The percentage of total sleep time to lights off and leaving bed assessed by sleep radar |
nights 1 - 7 during treatment |
|
Secondary |
Countermovement jump height |
|
7 days after treatment |
|
Secondary |
Ball speed velocity |
|
7 days after treatment |
|
Secondary |
Sprint test (0-20m) |
|
7 days after treatment |
|
Secondary |
Agility T-test |
|
7 days after treatment |
|
Secondary |
Maximal isometric handgrip strength |
|
7 days after treatment |
|
Secondary |
Flanker task |
|
7 days after treatment |
|
Secondary |
Changes in muscle damage markers |
Blood serum will be obtained to measure myoglobin concentration |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Secondary |
Changes in muscle enzymes activity |
Blood serum will be obtained to measure creatine kinase activity |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Secondary |
Changes in inflammation markers |
Blood serum will be obtained to measure C-reactive protein concentration |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Secondary |
Changes in blood count |
Whole blood will be obtained to measure leukocyte count |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Secondary |
Changes in anabolic hormones |
Blood serum will be obtained to measure testosterone concentration |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Secondary |
Changes in catabolic hormones |
Blood serum will be obtained to measure cortisol concentration |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Secondary |
Changes in kidney function markers |
Blood serum will be obtained to measure creatinine concentration |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Secondary |
Changes in the purine metabolism marker |
Blood serum will be obtained to measure uric acid concentration |
1) baseline - 2) 7th day of treatment - before the supplementation, 3) 7th day of treatment - before the performance test, 4) 7th day of treatment - immediately after the performance test |
|
Secondary |
Changes in hemoglobin concentration |
Arterialized blood will be obtained to measure hemoglobin concentration |
1) Before the performance test 2) 3 minutes after the performance test 3) 10 minutes after the performance test 4) 20 minutes after the performance test |
|
Secondary |
Changes in hematocrit |
Arterialized blood will be obtained to measure hematocrit |
1) Before the performance test 2) 3 minutes after the performance test 3) 10 minutes after the performance test 4) 20 minutes after the performance test |
|
Secondary |
Changes in plasma volume |
The change in plasma volume will be calculated using the hemoglobin and hematocrit results |
1) Before the performance test 2) 3 minutes after the performance test 3) 10 minutes after the performance test 4) 20 minutes after the performance test |
|